Sayana Press Subcutaneous DMPA
for Self or Clinician Administration
Sayana is bioequivalent to IM DMPA and similar in efficacy, benefits, side effects and risks.
Sayana is injected subcutaneously into the abdomen or anterior thigh and some users report skin reactions or dimpling. It is licensed for Clinician administration or for users to self-administer
and for administration at 13 weeks +/- 7 day intervals. The cost is only slightly higher than for IM DMPA.
IM DMPA for clinician administration will continue to be available.
Some women will continue to prefer this option. However Sayana offers significant benefits for patient autonomy; once users have mastered the simple injection device, they can have a 3 further doses of Sayana to keep at home and self-inject; up to a year of highly reliable contraception without visits to healthcare providers.
Self-injection teach is an easy technique, taught by health care professional and supported by free resources from firstname.lastname@example.org or from www.medisa.com
who will mail supplies to NHS/GP addresses. You will need to register with your GMC or NMC number. Resources include;
- Self-injection guide leaflets
- Placebo Sayana injections for practising technique
- Text reminder cards to organise reminder when injection next due
The same sources also provide free small sharps bins for users to store used sharps safely over the course of a year for subsequent handling through NHS disposal routes.
There is a PGD
for use by non-prescribing nurses who are regularly providing contraceptive services.
Lothian Formulary puts Sayana equal first-line with IM Depo Provera
UK MEC treats Sayana as equivalent to Depo Provera.
Download checklists for self-administration teaching and for general Sayana counselling about Sayana as a contraceptive method.
Follow this link for a 2013 summary of Sayana’s characteristics. Note that this review pre-dates the self-injection licence but the product is unchanged.